Organicell Regenerative Medicine, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OCEL research report →
Companywww.organicell.com
Organicell Regenerative Medicine, Inc. , a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19.
- CEO
- Harry L. Leider FACPE,
- IPO
- 2016
- Employees
- 20
- HQ
- Miami, FL, US
Price Chart
Valuation
- Market Cap
- $19.97M
- P/E
- -3.75
- P/S
- 3.60
- P/B
- -50.28
- EV/EBITDA
- -3.80
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 81.62%
- Op Margin
- -90.21%
- Net Margin
- -92.35%
- ROE
- 329.90%
- ROIC
- 1796.06%
Growth & Income
- Revenue
- $5.20M · 12.53%
- Net Income
- $-5,521,000 · -17.34%
- EPS
- $-0.86 · -16.22%
- Op Income
- $-5,386,000
- FCF YoY
- 48.90%
Performance & Tape
- 52W High
- $4.80
- 52W Low
- $0.90
- 50D MA
- $1.56
- 200D MA
- $2.21
- Beta
- 1.36
- Avg Volume
- 4.72K
Get TickerSpark's AI analysis on OCEL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 23 | Leider Harry L. | buy | 500,000 |
| Jun 28, 23 | Leider Harry L. | buy | 549,450 |
| Dec 19, 23 | Leider Harry L. | sell | 5,248 |
| Jul 7, 23 | Skycrest Holdings, LLC | buy | 320,710 |
| Jun 29, 23 | Skycrest Holdings, LLC | buy | 200,000 |
| Jun 28, 23 | Skycrest Holdings, LLC | buy | 400,000 |
| Jun 28, 23 | Leider Harry L. | buy | 549,450 |
| Jun 26, 23 | Skycrest Holdings, LLC | buy | 800,000 |
| Sep 6, 23 | Golub Howard Lawrence | other | 50,000,000 |
| Sep 6, 23 | Leider Harry L. | other | 57,000,000 |
Our OCEL Coverage
We haven't published any research on OCEL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OCEL Report →